Sangel Capital

Sangel Capital is a specialized venture investment institution dedicated to the biomedical sector. It focuses on life science and technology, leveraging experts to identify and nurture innovative growth enterprises. The firm manages diverse RMB and USD funds, deploying capital into early-stage bio-medicine, medical technology, and medical device companies.

Established in 2010 by Founding Partner Liu Mulong, Sangel Capital’s genesis was a differentiated investment strategy. Liu Mulong aimed to uncover high-potential ventures within life sciences, cultivating companies offering transformative solutions. The firm emphasizes original innovation and robust technological assets.

Sangel Capital partners with innovative emerging-market companies in the life sciences sector, providing strategic capital to scale breakthrough discoveries. Its long-term vision is to translate early-stage innovations into next-generation medical solutions, addressing unmet medical challenges and cultivating industry benchmarks.